1. Home
  2. AUB vs ACAD Comparison

AUB vs ACAD Comparison

Compare AUB & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$38.03

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$25.96

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUB
ACAD
Founded
1902
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.4B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
AUB
ACAD
Price
$38.03
$25.96
Analyst Decision
Strong Buy
Buy
Analyst Count
7
22
Target Price
$40.50
$30.00
AVG Volume (30 Days)
1.0M
1.2M
Earning Date
01-22-2026
02-25-2026
Dividend Yield
3.86%
N/A
EPS Growth
N/A
98.53
EPS
1.75
1.54
Revenue
$1,048,582,000.00
$1,047,118,000.00
Revenue This Year
$79.32
$15.16
Revenue Next Year
$14.97
$11.79
P/E Ratio
$21.87
$16.86
Revenue Growth
41.48
12.69
52 Week Low
$22.85
$13.40
52 Week High
$39.22
$28.35

Technical Indicators

Market Signals
Indicator
AUB
ACAD
Relative Strength Index (RSI) 63.18 45.95
Support Level $36.53 $25.90
Resistance Level $38.80 $27.06
Average True Range (ATR) 0.87 0.74
MACD 0.10 -0.21
Stochastic Oscillator 79.98 32.33

Price Performance

Historical Comparison
AUB
ACAD

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: